These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 33743960)

  • 21. A simple prognostic model involving prostate-specific antigen, alkaline phosphatase and albumin for predicting the time required to progress to castration-resistant prostate cancer in patients who received androgen deprivation therapy.
    Lv W; Shang H; Pei X; Chen Y; Xie H; He D; Wang X; Li L
    Int Urol Nephrol; 2017 Jan; 49(1):61-67. PubMed ID: 27837416
    [TBL] [Abstract][Full Text] [Related]  

  • 22. GR silencing impedes the progression of castration-resistant prostate cancer through the JAG1/NOTCH2 pathway via up-regulation of microRNA-143-3p.
    Zhang L; Jiang H; Zhang Y; Wang C; Xia X; Sun Y
    Cancer Biomark; 2020; 28(4):483-497. PubMed ID: 32568179
    [TBL] [Abstract][Full Text] [Related]  

  • 23. miR-30a inhibits androgen-independent growth of prostate cancer via targeting MYBL2, FOXD1, and SOX4.
    Li X; Jiao M; Hu J; Qi M; Zhang J; Zhao M; Liu H; Xiong X; Dong X; Han B
    Prostate; 2020 Jun; 80(9):674-686. PubMed ID: 32294305
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PTTG3P promotes gastric tumour cell proliferation and invasion and is an indicator of poor prognosis.
    Weng W; Ni S; Wang Y; Xu M; Zhang Q; Yang Y; Wu Y; Xu Q; Qi P; Tan C; Huang D; Wei P; Huang Z; Ma Y; Zhang W; Sheng W; Du X
    J Cell Mol Med; 2017 Dec; 21(12):3360-3371. PubMed ID: 28631396
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long noncoding RNA PTTG3P/miR-192-3p/CCNB1 axis is a potential biomarker of childhood asthma.
    Dai B; Sun F; Cai X; Li C; Liu F; Shang Y
    Int Immunopharmacol; 2021 Dec; 101(Pt B):108229. PubMed ID: 34717195
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pre-existing Castration-resistant Prostate Cancer-like Cells in Primary Prostate Cancer Promote Resistance to Hormonal Therapy.
    Cheng Q; Butler W; Zhou Y; Zhang H; Tang L; Perkinson K; Chen X; Jiang XS; McCall SJ; Inman BA; Huang J
    Eur Urol; 2022 May; 81(5):446-455. PubMed ID: 35058087
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Androgen-induced miR-135a acts as a tumor suppressor through downregulating RBAK and MMP11, and mediates resistance to androgen deprivation therapy.
    Wan X; Pu H; Huang W; Yang S; Zhang Y; Kong Z; Yang Z; Zhao P; Li A; Li T; Li Y
    Oncotarget; 2016 Aug; 7(32):51284-51300. PubMed ID: 27323416
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prostate cancer bone metastases acquire resistance to androgen deprivation via WNT5A-mediated BMP-6 induction.
    Lee GT; Kang DI; Ha YS; Jung YS; Chung J; Min K; Kim TH; Moon KH; Chung JM; Lee DH; Kim WJ; Kim IY
    Br J Cancer; 2014 Mar; 110(6):1634-44. PubMed ID: 24518599
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ACSL4 promotes prostate cancer growth, invasion and hormonal resistance.
    Wu X; Deng F; Li Y; Daniels G; Du X; Ren Q; Wang J; Wang LH; Yang Y; Zhang V; Zhang D; Ye F; Melamed J; Monaco ME; Lee P
    Oncotarget; 2015 Dec; 6(42):44849-63. PubMed ID: 26636648
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transcriptome Sequencing Reveals PCAT5 as a Novel ERG-Regulated Long Noncoding RNA in Prostate Cancer.
    Ylipää A; Kivinummi K; Kohvakka A; Annala M; Latonen L; Scaravilli M; Kartasalo K; Leppänen SP; Karakurt S; Seppälä J; Yli-Harja O; Tammela TL; Zhang W; Visakorpi T; Nykter M
    Cancer Res; 2015 Oct; 75(19):4026-31. PubMed ID: 26282172
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Down-regulated PTTG1 expression promotes the senescence of human prostate cancer LNCaP-AI].
    Wei YY; Song XM; Xiong ZH; Lu KQ; Zheng L; Cao XL
    Zhonghua Nan Ke Xue; 2019 Mar; 25(3):216-222. PubMed ID: 32216239
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential expression of androgen receptor variants in hormone-sensitive prostate cancer xenografts, castration-resistant sublines, and patient specimens according to the treatment sequence.
    Honda M; Kimura T; Kamata Y; Tashiro K; Kimura S; Koike Y; Sato S; Yorozu T; Furusato B; Takahashi H; Kiyota H; Egawa S
    Prostate; 2019 Jun; 79(9):1043-1052. PubMed ID: 30998834
    [TBL] [Abstract][Full Text] [Related]  

  • 33. EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer.
    Heidenreich A; Bastian PJ; Bellmunt J; Bolla M; Joniau S; van der Kwast T; Mason M; Matveev V; Wiegel T; Zattoni F; Mottet N;
    Eur Urol; 2014 Feb; 65(2):467-79. PubMed ID: 24321502
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SRD5A gene polymorphism in Japanese men predicts prognosis of metastatic prostate cancer with androgen-deprivation therapy.
    Shiota M; Fujimoto N; Yokomizo A; Takeuchi A; Itsumi M; Inokuchi J; Tatsugami K; Uchiumi T; Naito S
    Eur J Cancer; 2015 Sep; 51(14):1962-9. PubMed ID: 26169017
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Constitutive Intrinsic Inflammatory Signaling Circuit Composed of miR-196b, Meis2, PPP3CC, and p65 Drives Prostate Cancer Castration Resistance.
    Jeong JH; Park SJ; Dickinson SI; Luo JL
    Mol Cell; 2017 Jan; 65(1):154-167. PubMed ID: 28041912
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aromatase-induced endogenous estrogen promotes tumour metastasis through estrogen receptor-α/matrix metalloproteinase 12 axis activation in castration-resistant prostate cancer.
    Liang Z; Cao J; Tian L; Shen Y; Yang X; Lin Q; Zhang R; Liu H; Du X; Shi J; Zhang J
    Cancer Lett; 2019 Dec; 467():72-84. PubMed ID: 31499120
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Demethylation of the miR-146a promoter by 5-Aza-2'-deoxycytidine correlates with delayed progression of castration-resistant prostate cancer.
    Wang X; Gao H; Ren L; Gu J; Zhang Y; Zhang Y
    BMC Cancer; 2014 May; 14():308. PubMed ID: 24885368
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long Non-coding RNA AFAP1-AS1 Facilitates Prostate Cancer Progression by Regulating miR-15b/IGF1R Axis.
    Liu B; Jiang HY; Yuan T; Zhou WD; Xiang ZD; Jiang QQ; Wu DL
    Curr Pharm Des; 2021; 27(41):4261-4269. PubMed ID: 34126893
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PTTG1 regulated by miR-146a-3p promotes bladder cancer migration, invasion, metastasis and growth.
    Xiang W; Wu X; Huang C; Wang M; Zhao X; Luo G; Li Y; Jiang G; Xiao X; Zeng F
    Oncotarget; 2017 Jan; 8(1):664-678. PubMed ID: 27893422
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Androgen deprivation‑induced OPHN1 amplification promotes castration‑resistant prostate cancer.
    Liu J; Zhang Y; Li S; Sun F; Wang G; Wei D; Yang T; Gu S
    Oncol Rep; 2022 Jan; 47(1):. PubMed ID: 34738630
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.